India DNA Vaccine Market to Reach $41.6 Million by 2035

The India DNA vaccine market was valued at $27.5 million in 2025 and is projected to reach $41.6 million by 2035, registering a CAGR of 4.3% during the forecast period from 2026 to 2035. India’s DNA Vaccine market is gaining momentum as government-led innovation initiatives and scalable biomanufacturing capacity accelerate product development and regulatory acceptance. Strong public sector support through strategic missions has strengthened the country’s biotechnology ecosystem, enabling advanced vaccine platforms such as plasmid DNA vaccines to move from research into deployment. The development and national approval of ZyCoV-D, the world’s first indigenously developed plasmid DNA vaccine for COVID-19, has validated DNA vaccine platforms, increasing industry confidence and encouraging further investment. In parallel, India’s broader bioeconomy has been expanding rapidly, supported by policy and funding that reinforce domestic R&D and manufacturing capabilities. This structured policy environment is enabling companies and research institutions to scale DNA vaccine pipelines, especially for infectious diseases, improving the overall market outlook for this technology platform.

Browse the full report description of “India DNA Vaccine Market Size, Share & Trends Analysis Report by Type (Animal DNA Vaccine, and Human DNA Vaccine), by Technology (Plasmid DNA Vaccines Technology, and Plasmid DNA Delivery Technology), by Application (Oncology, Infectious Diseases, and Others), Forecast Period 2026-2035” at https://www.omrglobal.com/industry-reports/indian-dna-vaccines-market

Official statistics underscore this growth orientation: India’s bioeconomy reached $165.7 billion in 2024, up from $10 billion in 2014, with a compound annual growth rate of nearly 18% over the past four years, and a national target of $300 billion by 2030, reinforcing biotechnology as a key economic driver. The bioeconomy contributes over 4% of GDP, and India’s robust vaccine production capacity supports its status as a major global vaccine hub. Notably, India is recognized as one of the top global producers of vaccines and developed the world’s first DNA COVID-19 vaccine. This macro-biotech expansion reflects an environment conducive to DNA vaccine innovation and commercialization within the country.

Key Findings:

• India’s bioeconomy expanded from $10 billion (2014) to $165.7 billion (2024), highlighting transformative sector growth.

• The bioeconomy now contributes 4.25% of national GDP, showing biotechnology’s rising economic impact.

• Government targets a $300 billion bioeconomy by 2030, underlining priority policy support.

• India has developed and approved ZyCoV-D, the world’s first indigenously developed plasmid DNA vaccine, marking a major technology milestone.

• The National Biopharma Mission (NBM), backed by the World Bank, has catalyzed vaccine research and platform scaling.

• Domestic vaccine production capacity and distribution systems are increasingly oriented toward advanced biotechnologies, including DNA-based platforms.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Type
  • Technology
  • Application
• Competitive Landscape – Bharat Biotech International Ltd., Inovio Pharmaceuticals, Inc., Recipharm AB, VGXI, Inc., Zydus Lifesciences Ltd, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

India DNA Vaccine Market Report Segment

By Type

• Animal DNA Vaccine
• Human DNA Vaccine

By Technology

• Plasmid DNA Vaccines Technology
• Plasmid DNA Delivery Technology

By Application

• Oncology
• Infectious Diseases
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-dna-vaccines-market